Proton Pump Inhibitors and Cancer Risk

Investigators evaluate cancer risk tied to extended acid suppression therapy.

1

Long-term proton pump inhibitor exposure showed no increase in gastric non-cardia adenocarcinoma risk in a large Nordic study.
2

The study analyzed data from 17,232 patients with gastric non-cardia adenocarcinoma and 172,297 matched controls.
3

Long-term use of proton pump inhibitors was found in 10.2% of cases and 9.5% of controls, with no significant risk difference after adjustment.
4

Sensitivity analyses indicated increased risk estimates under specific conditions, but overall results remained null after extensive adjustments.
5

The study's observational design had limitations, including potential residual confounding and unmeasured variables like dietary exposures.

1